2022, Number 2
<< Back Next >>
Med Int Mex 2022; 38 (2)
Hypouricemia: a forgotten entity
Sánchez-Pérez H, Carrillo-Esper R, Zavala-González MÁ, Carrillo-Córdova DM
Language: Spanish
References: 25
Page: 388-396
PDF size: 480.12 Kb.
ABSTRACT
Hypouricemia is a biochemical disorder and marker for primary or secondary tubulophaty
and other underlying illnesses, defined as a serum uric acid concentration
lesser than 2 mg/dL. It occurs in approximately 2% of hospitalized patients and in
lesser than 0.5% of general population. Hypouricemia may be caused by decreased
uric acid production, uric acid oxidation or decreased renal tubular reabsortion. Differential diagnosis of hypouricemia is usually made by evaluating the fractional excretion of uric acid. Patients with hypouricemia may have an increased incidence of acute
kidney injury related to exercise and reduced kidney function. The aim of this paper
is to review current concepts related to hypouricemia and emphasize the importance
of its evaluation and follow-up.
REFERENCES
Praetorius E, Kirk JE. Hypouricemia: With evidence for tubular elimination of uric acid. J Lab Clin Med 1950; 35:865-868.
Sperling O, Weinberger A, Oliver I, Liberman U, De Vries A. Hypouricemia, hypercalciuria, and decreased bone density. A new hereditary syndrome. Purine Metabolism in Man. Springer US 1974; 717-721.
Mount DB, Kwon CY, Zanid-Nejad K. Renal urate transport. Rheums Dis Clin N Am 2006; 32: 313-331. doi: 10.1016/j. rdc.2006.02.006.
Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol 2016; 213: 8-14. doi: 10.1016/j.ijcard.2015.08.109.
Esparza-Martin N, Garcia Nieto V. Hypouricemia and tubular transport of uric acid. Nefrologia 2011; 31: 44-50. doi: 10.3265/Nefrologia.pre2010.Oct.10588.
Sperling O, Scriver CR, Beaudet AL, Sky WS, Valle D. The metabolic basis of inherited disease. New York: McGraw Hill 1989; 6: 2605-2619.
Ramsdell CM, Kelley W. The clinical significance of hypouricemia. Ann Intern Med 1973; 78: 239-422. doi: 10.7326/0003-4819-78-2-239.
Sebesta I, Stiburkova B, Bartl J, Ichida K, Hosoyamada M, Taylor J, Marinaki A. Diagnostic tests for primary renal hypouricemia. Nucleosides Nucleotides Nucleic Acids 2011; 30: 1112-1116. doi: 10.1080/15257770.2011.611483.
Mayaudon H, Burnat P, Eulry F, Payen C, Dupuy O, Ducorps M, Bauduceau B. Hereditary xanthinuria, rare cause of hypo-uric acidemia. 2 cases. Presse Med 1998; 27: 661-663.
Garcia-Amorin Z, Perez-Mendez C, Perez-Garcia I, Alonso-Bernardo L, Ramos-Polo E, Lopez-Sastre J, et al. Hypouricemia and cellular immunodeficiency associated with purine-nucleoside phosphorylase deficiency. An Esp Pediatr 1991; 34: 472-474.
De Coek NM. Serum urate and urate clearance in diabetes mellitus. Australas Ann Med 1965; 14: 205-209.
Passeron A, Blanchard A, Capron L. Hypo-uricemia in the syndrome of inappropriate secretion of antidiuretic hormone: A prospective study. Rev Med Interne 2010; 31: 665-669. doi: 10.1016/j.revmed.2010.05.001.
Eraly SA, Vallon V, Rieg T, Gangoiti JA, Wikoff WR, Siuzdak G, et al. Multiple organic anion transporters contribute to net renal excretion of uric acid. Physiol Genomics 2008; 33: 180-192. doi: 10.1152/physiolgenomics.00207.2007.
Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002; 417: 447-452. doi: 10.1038/nature742.
Hamajima N, Okada R, Kawai S, Hishida A, Morita E, Yin G, Asai Y. Significant association of serum uric acid levels with SLC2A9 rs11722228 among a Japanese population. Mol Genet Metab 2011; 103: 378-382. doi: 10.1016/j. ymgme.2011.04.001.
Dinour D, Bahn A, Ganon L. URAT1 mutations cause renal hypouricemia type 1 in Iraqi Jews. Nephrol Dial Transplant 2011; 26: 2175-2181. doi: 10.1093/ndt/gfq722.
Li S, Sanna S, Maschio A, Busonero F, Usala G, Mulas A, Bandinelli S. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet 2007; 3: 194. doi: 10.1371/journal.pgen.0030194.
Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 2008; 40: 437-442. doi: 10.1038/ng.106.
Son CN, Kim JM, Kim SH, Cho SK, Choi CB, Sung YK, et al. Prevalence and possible causes of hypouricemia at a tertiary care hospital. Korean J Intern Med 2016; 31 (5): 971. doi: 10.3904/kjim.2015.125.
Kuwabara M, Niwa K, Ohtahara A, Hamada T, Miyazaki S, Mizuta E, et al. Prevalence and complications of hypouricemia in a general population: A large scale cross-sectional study in Japan. Plos One 2017; 27: 12. doi: 10.1371/journal. pone.0176055.
Wakasugi M, Kazama JJ, Narita I, Konta T, Fujimoto S, Iseki K, et al. Association between hypouricemia and reduced kidney function: a cross-sectional population-based study in Japan. Am J Nephrol 2015; 41: 138-146. doi: 10.1159/000381106.
Kanda E, Muneyuki T, Kanno Y, Suwa K, Nakajima K. Uric acid level has a U-shaped association with loss of kidney function in healthy people: A prospective cohort study. PLoS One 2015; 10.2: e0118031. doi: 10.1371/journal. pone.0118031.
Sugihara S, Hisatome I, Kuwabara M, Niwa K, Maharani N, Kato M, et al. Depletion of uric acid due to SLC22A12 (URAT1) loss-of-function mutation causes endothelial dysfunction in hypouricemia. Circ J 2015; 79: 1125-1132. doi: 10.1253/circj.CJ-14-1267.
Shichiri M, Iwamoto H, Marumo F. Diabetic hypouricemia as an indicator of clinical nephropathy. Am J Nephrol 1990; 10: 115-122. doi: 10.1159/000168065.
Bo S, Cavallo-Perin P, Gentile L, Repetti E, Pagano G. Hypouricemia and hiperuricemia in type 2 diabetes: two different phenotypes. Eur J Clin Invest 2001; 31: 318-321. doi: 10.1046/j.1365-2362.2001.00812.x.